- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Luckie & Company Launches Healthcare Division
Marketing solutions agency Luckie announced the launch of "Luckie Health," a dedicated practice focused exclusively on solving business challenges for healthcare brands. Led by a group of former pharma marketing executives, Luckie Health will offer a business-first, data-centric approach to the challenges of healthcare marketing.
The practice is being led by Kamala Prince who spent 20+ years managing patient marketing and product launches at biotech and pharmaceutical companies including United Therapeutics, GlaxoSmithKline and ViiV Healthcare.
She is joined by Brian Lamkin, Luckie's SVP of analytics and integrated solutions, and former director of Rx analytics for Galderma.
John Petersen rounds out the leadership team as VP of healthcare solutions. Petersen joined Luckie in June 2022 after 30 years in consumer healthcare and pharmaceuticals, working with L'Oréal, Galderma, Novartis, AstraZeneca, and most recently as CCO of Crown Laboratories.
The group reports to Luckie CEO, John Gardner, who's managed marketing campaigns for Novartis, Eli Lily, Bayer Consumer Health, GSK, Merck and others.
Beyond the Scrubs: Understanding Healthcare Providers as People for Increased Engagement
March 28th 2024The benefits of adopting a humanized approach to healthcare provider marketing extend across the healthcare spectrum, enhancing engagement rates, brand loyalty, and marketing ROI, while also driving better outcomes for patients.
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.
